21556 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
RADIOTRACERS AND THERAPEUTICS BINDING TO FIBROBLAST ACTIVATION PROTEIN (FAP)
#2RADIOLABELING AND FORMULATION FOR SCALE UP OF 64Cu-DOTATATE
#3LOADING OF HUMAN CAR T-CELLS WITH SUPERPARAMAGNETIC IRON-BASED PARTICLES FOR MAGNETIC TARGETING
#4LOADING OF HUMAN CAR T-CELLS WITH SUPERPARAMAGNETIC IRON-BASED PARTICLES FOR MAGNETIC TARGETING
#5PSMA-TARGETING COMPOUNDS AND USES THEREOF
#6PSMA-targeting compounds and uses thereof
#7METHODS OF TREATING CANCER
#8Radiolabeling and formulation for scale up of Cu-DOTATATE
#9PSMA targeted fluorescent agents for image guided surgery
#10IN VIVO STABLE HG-197(M) COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF IN NUCLEAR MEDICAL DIAGNOSTICS AND ENDORADIONUCLIDE THERAPY (THERANOSTICS)
#11Preparation of metal-pyridine derivative complexes for use in medical imaging
#12PSMA targeted fluorescent agents for image guided surgery
#13KIT FOR LABELING A PROSTATE-SPECIFIC MEMBRANE ANTIGEN LIGAND WITH A RADIOACTIVE ISOTOPE
#14PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY
#152,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based MRI contrast agents and 52MN based PET contrast agents
#16Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents
#17COUPLED IDENTIFICATION AND TREATMENT OF CANCER
#18PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY
#19PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY
#20METHOD FOR LABELING A PROSTATE-SPECIFIC MEMBRANE ANTIGEN LIGAND WITH A RADIOACTIVE ISOTOPE
#21COMPOSITIONS COMPRISING VITAMIN B12 AND INTRINSIC FACTOR AND METHODS OF USE THEREOF
#22Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
#23Tetrahydroxamate chelators of zirconium89 and niobium90 for use in diagnostic applications
#24Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents
#25PSMA-targeting compounds and uses thereof
#26METAL COMPLEXES AS IMAGING AGENTS
#27Folate conjugates of albumin-binding entities
#28Compositions, methods of synthesis and use of carbohydrate targeted agents
#29Methods for tumor diagnosis and therapy
#30Coupled identification and treatment of cancer
#31Molecular probes for multimodality imaging of anionic membrane surfaces
#32Agents and methods for visualizing analytes
#33COMPOUNDS, COMPOSITIONS, METHODS OF SYNTHESIS, AND METHODS OF TREATMENT
#34Methods for tumor diagnosis and therapy
#35PSMA-targeting compounds and uses thereof
#36Coupled identification and treatment of cancer
#37Compounds, compositions, methods of synthesis, and methods of treatment
#38Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agents
#39Compounds for tumor diagnosis and therapy